Sodium-Glucose Cotransporter 2 Inhibitor Use and Outcomes in Transthyretin Amyloid Cardiomyopathy
Related Posts
Brownell N, Solomon N, Greene SJ, Chiswell K, Vaduganathan M, Yancy C, Hsue P, Ziaeian B, Fonarow GC. Clinical Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors Among[...]
Rozanski A, Gransar H, Miller R, Slomka P, Han D, Hayes S, Friedman J, Berman D. Temporal trends in the clinical utilization of cardiac imaging[...]
Cai A, Liu L, Feng Y, Zhou Y, Li L, Bozkurt B, Januzzi JL, Lam CSP, Fonarow GC, Pandey A, Zhou Z, Cheng Y, Bayes-Genis[...]